诊断性检查在CAR-T细胞相关神经毒性管理中的影响
该研究在法国雷恩大学医院纳入2018年8月至2023年1月连续接受CAR-T细胞治疗的190例患者,其中91例(48%)发生ICANS。MRI、腰椎穿刺和脑电图分别有4%、7%和16%的治疗影响,脑电图影响最大,MRI和腰椎穿刺影响有限,作者质疑系统性MRI和腰椎穿刺的必要性。
要点
- 190例接受CAR-T细胞治疗的患者中91例(48%)发生ICANS。
- 脑电图对16%的ICANS患者产生治疗修改,影响最大。
- MRI和腰椎穿刺的治疗影响分别为4%和7%,影响有限。
核心结论
- 脑电图是治疗影响最大的诊断性检查,而MRI和腰椎穿刺的治疗影响似乎有限。
- 结果强调脑电图在当前指南中的作用,但质疑系统性MRI和腰椎穿刺的必要性,后者或可留给治疗医师酌情决定。
研究设计与样本
- 研究为在法国雷恩大学医院接受CAR-T细胞治疗的真实世界患者队列。
- 2018年8月至2023年1月共纳入190例连续接受CAR-T细胞治疗的患者。
主要发现
- 190例患者中91例(48%)发生ICANS。
- 91例ICANS患者中71例(78%)进行了MRI,尽管异常发现常见,但仅4%的患者有治疗影响。
- 91例ICANS患者中43例(47%)进行了腰椎穿刺,7%的患者因此预防性使用抗微生物药物,但最终未检出感染。
- 91例ICANS患者中51例(56%)进行了系统性脑电图,16%的患者因此治疗修改。
临床怎么用
- 作者认为脑电图是治疗影响最大的诊断性检查,而MRI和腰椎穿刺的治疗影响似乎有限。
- 作者质疑系统性MRI和腰椎穿刺的必要性,认为或可留给治疗医师酌情决定。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
International guidelines regarding the management of immune effector cell-associated neurotoxicity syndrome (ICANS) recommend several diagnostic investigations, including magnetic resonance imaging (MRI), lumbar puncture (LP), and electroencephalogram (EEG) based on ICANS grade. However, the impact of these investigations has not yet been evaluated. Here, we aimed to describe the role of MRI, LP, and EEG in the management of ICANS in a cohort of real-life patients treated with chimeric antigen receptor (CAR) T cells at the University Hospital of Rennes, France. Between August 2018 and January 2023, a total of 190 consecutive patients were treated with CAR T cells. Among those, 91 (48%) developed ICANS. MRI was performed in 71 patients (78%) with ICANS, with a therapeutic impact in 4% of patients, despite frequent abnormal findings. LP was performed in 43 patients (47%), which led to preemptive antimicrobial agents in 7% of patients, although no infection was eventually detected. Systematic EEG was performed in 51 patients (56%), which led to therapeutic modifications in 16% of patients. Our study shows that EEG is the diagnostic investigation with the greatest therapeutic impact, whereas MRI and LP appear to have a limited therapeutic impact. Our results emphasize the role of EEG in the current guidelines but question the need for systematic MRI and LP, which might be left to the discretion of the treating physician.
引用
- Mauget M, Lemercier S, Quelven Q, et al. Impact of diagnostic investigations in the management of CAR T-cell-associated neurotoxicity. Blood Adv. 2024. PMID: 38501964. doi:10.1182/bloodadvances.2023011669
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。